⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Viridian Therapeutics, Inc. Common Stock

$30.16
-0.70 (-2.27%)

Volume:

1.355M ($40.87M)

Market Capitalization:

$3.42B

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Viridian Therapeutics Market Segments

Regular Trading Hours

-0.53(-1.73%)
Open$30.69
Close$30.16
Low$30.10
Low Change-0.60 (-1.94%)
High$31.37
High Change+0.68 (+2.22%)
Range$1.28
Volume1.355M
Dollar Volume$40.87M

Premarket

+0.00(+0.00%)
Open$30.90
Close$30.90
Low$30.90
Low Change0.00 (0.00%)
High$30.90
High Change+0.00 (+0.00%)
Range$0.00
Volume111
Dollar Volume$3.43K

Overnight

*No Trades in Segment

After Hours Yesterday

+0.00(+0.00%)
Open$30.87
Close$30.87
Low$30.86
Low Change-0.01 (-0.03%)
High$30.87
High Change+0.00 (+0.00%)
Range$0.01
Volume222.807K
Dollar Volume$6.88M

Regular Trading Hours Yesterday

+0.62(+2.05%)
Open$30.24
Close$30.86
Low$29.81
Low Change-0.43 (-1.42%)
High$30.96
High Change+0.72 (+2.38%)
Range$1.15
Volume971.265K
Dollar Volume$29.97M

Premarket Yesterday

-0.05(-0.16%)
Open$30.40
Close$30.35
Low$30.35
Low Change-0.05 (-0.16%)
High$30.40
High Change+0.00 (+0.00%)
Range$0.05
Volume1.011K
Dollar Volume$30.68K

Viridian Therapeutics Top Trades

Viridian Therapeutics's top trade so far today returned +2.22%, while the top short trade returned -3.86%.

Viridian Therapeutics Moving Averages

5 Day Moving Average (SMA5)$30.72
10 Day Moving Average (SMA10)$29.01
20 Day Moving Average (SMA20)$26.13
50 Day Moving Average (SMA50)$22.75
100 Day Moving Average (SMA100)$21.86
200 Day Moving Average (SMA200)$21.56

Viridian Therapeutics Statistics

Average Volume (30 Days)2.69M
P/E Ratio (Current)-8.71
EPS (Current)-$3.50
Dividend Yield0.00%
Free Cash Flow-$343.44M
Cash Ratio2.47
Current Ratio14.46
Quick Ratio14.46
Debt to Equity0.63
Enterprise Value$3.65B
EV to EBITDA-7.79
EV to Sales138.83
Price to Book5.96
Price to Cash Flow—
Price to Free Cash Flow—
Price to Sales131.56
Return on Assets-0.39%
Return on Equity-0.68%

Viridian Therapeutics Stock Splits

There have been 2 stock splits for Viridian Therapeutics (VRDN). The last reverse stock split occured on November 13, 2020 and reduced the outstanding shares at a ratio of 15:1.

DateTypeRatio
Nov 13, 2020Reverse15:1
Nov 7, 2016Reverse15:1

Viridian Therapeutics Dividends

There have been no dividends for Viridian Therapeutics (VRDN).